Quarterly report [Sections 13 or 15(d)]

FAIR VALUE MEASUREMENTS (Tables)

v3.25.1
FAIR VALUE MEASUREMENTS (Tables)
9 Months Ended
Jan. 31, 2025
Fair Value Disclosures [Abstract]  
Schedule of fair value of financial liabilities
               
Description   Level   January 31, 2025     April 30, 2024  
Liabilities:                    
Warrant liability   3   $ 2,384,000     $ 10,784,000  
Bifurcated embedded derivative   3   $     $ 2,184,000  
Schedule of change in the fair value of the warrant liability
     
    Three Months Ended  
    January 31, 2025  
Balance on October 31, 2024   $ 6,871,000  
Issuance of warrants      
Change in fair value of warrant liability     (4,487,000 )
Balance on January 31, 2025   $ 2,384,000  

 

    Nine Months Ended  
    January 31, 2025  
Balance on April 30, 2024   $ 10,784,000  
Issuance of warrants      
Change in fair value of warrant liability     (8,400,000 )
Balance on January 31, 2025   $ 2,384,000  
Schedule of embedded derivative liability
       
    Nine Months Ended  
    January 31, 2025  
Balance on April 30, 2024   $ 2,184,000  
Issuance of convertible preferred stock with bifurcated embedded derivative liability      
Change in fair value of bifurcated embedded derivative     (2,184,000 )
Balance on January 31, 2025   $  
Schedule of fair values of financial instruments by class
               
    Level   January 31, 2025     April 30, 2024  
Financial Assets                    
Marketable equity securities   1   $ 372,632     $  
Convertible note receivable – investment in debt security   3   $ 3,356,000     $ 2,755,000  
Warrant asset – Femasys   3   $ 3,322,000     $ 5,152,000  
Investment in preferred stock - TNF   3   $ 15,768,000     $  
Warrant asset – TNF   3   $ 2,862,000     $